MED19 anticorps (C-Term)
Aperçu rapide pour MED19 anticorps (C-Term) (ABIN2313717)
Antigène
Voir toutes MED19 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 160-188, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- MED19, CT (MED19, LCMR1, Mediator of RNA polymerase II transcription subunit 19, Lung cancer metastasis-related protein 1, Mediator complex subunit 19)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- MED19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 160-188 amino acids from the C-terminal region of human MED19.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MED19 (Mediator Complex Subunit 19 (MED19))
-
Autre désignation
- MED19
-
NCBI Accession
- NP_703151
-
UniProt
- A0JLT2
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-